| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |